Skip to main content

DekaBank Deutsche Girozentrale

Bank

Position in BBIO — BridgeBio Pharma, Inc.

CIK 1456228 FRANKFURT, 2M

Position in BBIO

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$7,448,000
+$22,000 QoQ
Shares Held
100,000
0.0% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#131
of 467 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BBIO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DekaBank Deutsche Girozentrale holds $122,810,940 across 48 Biotechnology names. BBIO ranks #4 (6.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 BBIO
BridgeBio Pharma, Inc.
This page
100,000 $7,448,000

All Filings in BBIO

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,448,000 100,000
2026-03-31 $7,426,000 100,000
2025-12-31 $3,355 100,000
2025-09-30 $5,194,000 100,000
2025-06-30 $4,318,000 100,000
2025-03-31 $3,457,000 100,000
2024-12-31 $2,744,000 100,000
2024-09-30 $2,546,000 100,000
2024-06-30 $2,533,000 100,000
2024-03-31 $3,092,000 100,000
2023-12-31 $4,037,000 100,000
2023-09-30 $2,637,000 100,000
2023-06-30 $1,720,000 100,000
2023-03-31 $1,658,000 100,000
2022-12-31 $381,000 50,000
2022-09-30 $497,000 50,000
2022-06-30 $361,384 39,800
2022-03-31 $403,970 39,800
2021-12-31 $603,816 36,200
2021-09-30 $1,649,824 35,200
2021-06-30 $3,243,072 53,200
2021-03-31 $3,277,120 53,200
2020-12-31 $2,716,402 38,200
2020-09-30 $1,504,552 40,100